Orion Biotech Opportunities’ $200 Million Initial Public Offering

Kirkland & Ellis counseled Orion Biotech Opportunities Corp. on the deal.Orion Biotech Opportunities Corp. closed its initial public offering (IPO) of 20,000,000 units at a price of $10…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now